bioAffinity Technologies (BIAF) Earnings Date & Reports

bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI)... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BIAF is expected to report earnings to rise 228.12% to -3150 cents per share on November 18

bioAffinity Technologies BIAF Stock Earnings Reports

Q3'26

Est.

$-31.50

Q2'26

Beat

by $21.90

Q1'26

Missed

by $0.73

Q4'25

Missed

by $0.61

Q3'25

Missed

by $4.65

The last earnings report on August 07 showed earnings per share of -960 cents, beating the estimate of -3150 cents. With 48.79K shares outstanding, the current market capitalization sits at 4.45M.

View a ticker or compare two or three

BIAF

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for BIAF